Looks like an exciting 2013 from the J.P. Morgan Healthcare Conference

20 of 40

Michael Garufi, chairman and CEO of Nicox

Michael Garufi, the Italian-born head of France's Nicox, came to JPM, in part, to broaden the company's ophthalmic diagnostic opportunities in the United States. The company, which also develops ophthalmic drugs, licenses and sells AdenoPlus, a diagnostic kit similar to a pregnancy test that swabs the eye to test for adenoviruses, which can cause a form of conjunctivitis that is highly contagious and does not respond to antibiotics. Garufi said he was on the lookout for outright acquisitions or licensing opportunities to broaden the company's portfolio. "There is some [opportunity] for new companies in the ophthalmic space for diagnostics, and we are trying to fill some of this space," he told FierceMedicalDevices of Nicox, a 40-employee company that is publicly traded in Europe.